Mangalam Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.30 M
as on 16-11-2024
- Company Age 36 Year, 25 Days
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 20.81 Cr
as on 16-11-2024
- Revenue 1147.55%
(FY 2023)
- Profit 94.19%
(FY 2023)
- Ebitda -5.99%
(FY 2023)
- Net Worth -3.34%
(FY 2023)
- Total Assets -5.09%
(FY 2023)
About Mangalam Laboratories
The Company is engaged in the Public Administration Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.30 M.
The company has closed loans amounting to ₹20.81 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Girdharilal Joshi and Shanti Surana serve as directors at the Company.
- CIN/LLPIN
U99999MH1988PTC049485
- Company No.
049485
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Nov 1988
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Mangalam Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Girdharilal Joshi  | Director | 22-Mar-2016 | Current |
| Shanti Surana | Director | 22-Mar-2016 | Current |
Financial Performance and Corporate Structure Insights of Mangalam Laboratories.
Mangalam Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1147.55% increase. The company also saw a substantial improvement in profitability, with a 94.19% increase in profit. The company's net worth dipped by a decrease of 3.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mangalam Laboratories?
In 2023, Mangalam Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Percept Financial Services Private LimitedActive 28 years 2 monthsGirdharilal Joshi is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab & Maharashtra Co-Operative Bank Limited Creation Date: 07 Apr 2014 | ₹5.00 M | Satisfied |
Punjab And Maharashtra Co-Operative Bank Limited Creation Date: 19 Jul 2013 | ₹20.01 Cr | Satisfied |
Nagar Urban Co-Op Bank Creation Date: 25 Nov 2004 | ₹3.00 M | Satisfied |
How Many Employees Work at Mangalam Laboratories?
Unlock and access historical data on people associated with Mangalam Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mangalam Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mangalam Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
